The US AI in healthcare market is estimated to grow significantly at a CAGR of 50.2% during the forecast period. The factors that are contributing significantly to the market growth include R&D, and high expenditure by the government as well as a private organization in AI technology. The US and Canada are the major economies of North America. The region has well-developed information communication technology (ICT) and employs the adoption of a large number of connected devices. 

The market is segmented on the basis of offering, end-user industry, and application. Based on offering, the market is divided into software & services and hardware. Based on the end-user industry, the market is segmented into hospitals & healthcare facilities, personal care, and biotechnology & pharmaceutical companies. Further, on the basis of application, the market is segmented into diagnosis, biomarker, virtual nursing assistance, remote monitoring of patients, drug discovery, and ai-enabled hospital care. Pfizer Inc. is one of the pharmaceutical companies that is using AI in drug discovery. The company has entered into a partnership with IBM Watson Health in December 2016, for accelerating drug discovery in immune oncology. It is an approach for the treatment of cancer by using immune system of the body to combat cancer.

Moreover, presence of players in the region providing assisted robotic surgeries also contribute in the growth of the market. A significant growth in the company’s revenue has been witnessed due to their advanced and innovative instruments that also fuels the growth of the market. The companies which are contributing to the growth of the US AI market include Microsoft Corp., IBM Corp., Google, LLC. and GE Healthcare. 

The market players are considerably contributing to the market growth by the adoption of various strategies including new product launch, merger, and acquisition, collaborations with government, funding to the start-ups and technological advancements to stay competitive in the market. For instance, in January 2018, Microsoft and Adaptive Biotechnologies entered in partnership to map the genetics of the human immune system, which will enable to detect cancers and other diseases at the early stage. The partnership enables top merge the immune sequencing technology of Adaptive Biotechnologies with Microsoft’s research, machine learning and cloud computing capabilities which enables disease diagnostics.

Research Methodology

The market study of the US AI in healthcare market is incorporated by extensive primary and secondary research conducted by the research team.  Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include

• Financial reports of companies involved in the market.
• Whitepapers, research-papers, and news blogs.
• Company websites and their product catalog.

The report is intended for IT companies, healthcare companies, research institutes, hospitals, and government organizations, and other market participants for the overall market and competitive analysis. The report provides an in-depth analysis on market size, intended quality of the service preferred by consumers. The report will serve as a source for 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

1. US AI in Healthcare Market Research and Analysis by Offering

2. US AI in Healthcare Market Research and Analysis by End-User Industry

3. US AI in Healthcare Market Research and Analysis by Application

The Report Covers

• Comprehensive research methodology of the US AI in healthcare market.
• This report also includes a detailed and extensive market overview with key analyst insights.
• An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
• Analysis of regional regulations and other government policies impacting the US AI in healthcare market.
• Insights about market determinants which are stimulating the US AI in healthcare market.
• Detailed and extensive market segments with regional distribution of forecasted revenues.
• Extensive profiles and recent developments of market players.